University of Oxford
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
An Alternative Booster Vaccine Against Meningitis and Ear Infections
Phase 3
Completed
- Conditions
- Invasive Streptococcus Pneumoniae Disease
- Interventions
- Biological: 10-valent pneumococcal conjugate vaccineBiological: 13-valent pneumococcal conjugate vaccine
- First Posted Date
- 2011-09-29
- Last Posted Date
- 2015-11-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 178
- Registration Number
- NCT01443416
- Locations
- 🇬🇧
Oxford Vaccine Group, Oxford, United Kingdom
Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines
Phase 3
Completed
- Conditions
- Pneumococcal Disease
- Interventions
- Biological: Prevenar 13Biological: Pneumovax II
- First Posted Date
- 2011-09-12
- Last Posted Date
- 2015-11-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 4
- Registration Number
- NCT01432158
- Locations
- 🇬🇧
Oxford Vaccine Group, Oxford, United Kingdom
A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours
Phase 2
Completed
- Conditions
- Breast CancerOvarian Cancer
- Interventions
- First Posted Date
- 2011-09-12
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 74
- Registration Number
- NCT01432145
- Locations
- 🇬🇧
Churchill Hospital, Oxford, United Kingdom
Study of the Effects of Commercial Air Travel on the Lungs
Completed
- Conditions
- Healthy VolunteersChuvash Polycythaemia
- Interventions
- Other: Commercial airline flight
- First Posted Date
- 2011-08-19
- Last Posted Date
- 2011-08-19
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 9
- Registration Number
- NCT01420224
- Locations
- 🇬🇧
University of Oxford, Oxford, United Kingdom
Transcranial Stimulation and Motor Training in Stroke Rehabilitation
Phase 2
- Conditions
- StrokeCerebrovascular DisordersCerebral InfarctionBrain Diseases
- Interventions
- Device: Anodal tDCSOther: Motor Training
- First Posted Date
- 2011-08-11
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 80
- Registration Number
- NCT01414582
- Locations
- 🇬🇧
Centre for Functional MRI of the Brain (FMRIB), Oxford, United Kingdom
PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases
Early Phase 1
- Conditions
- Metastatic Colorectal Cancer
- First Posted Date
- 2011-08-05
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT01410760
- Locations
- 🇬🇧
Oxford Radcliffe Hospitals NHS Trust, Oxford, United Kingdom
Understanding Typhoid Disease After Vaccination
Phase 2
Completed
- Conditions
- Typhoid FeverEnteric FeverTyphoid
- Interventions
- Biological: M10ZH09 vaccineBiological: Ty21aBiological: Vaccine placebo (excipients only)
- First Posted Date
- 2011-07-29
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 99
- Registration Number
- NCT01405521
- Locations
- 🇬🇧
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, United Kingdom
Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: AdCh63 ME-TRAP followed by MVA ME-TRAP
- First Posted Date
- 2011-06-23
- Last Posted Date
- 2012-10-03
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 30
- Registration Number
- NCT01379430
- Locations
- 🇰🇪
KEMRI/Wellcome Trust Programme, Centre for Geographic Medicine Research - Coast, Kilifi, Kenya
AdCh63 ME-TRAP and MVA ME-TRAP Malaria Vaccines Evaluation in Healthy Adults and Children in a Malaria Endemic Area
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: AdCh63 ME-TRAP, MVA ME-TRAPBiological: HDCRV
- First Posted Date
- 2011-06-15
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 52
- Registration Number
- NCT01373879
- Locations
- 🇬🇲
Dr Kalifa Bojang, Banjul, Gambia
Safety and Immunogenicity of Novel Vaccination Schedules With Malaria Vaccines AdCh63 ME-TRAP and MVA ME-TRAP
Phase 1
Completed
- Conditions
- Malaria
- Interventions
- Biological: Vaccination Schedule FourBiological: Vaccination Schedule ThreeBiological: Vaccination Schedule TwoBiological: Vaccination Schedule FiveBiological: Vaccination Schedule OneBiological: Vaccination Schedule SixBiological: Vaccination Schedule Seven
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2013-07-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 39
- Registration Number
- NCT01364883
- Locations
- 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath